100 related articles for article (PubMed ID: 2185935)
1. Insulin therapy on the peritoneal route: effects on glucose control in experimental insulin dependent diabetes.
Fischer U; Fritze K; Freyse EJ
Exp Clin Endocrinol; 1990 Feb; 95(1):11-21. PubMed ID: 2185935
[TBL] [Abstract][Full Text] [Related]
2. Intraindividual comparison of pharmacokinetics of insulin after intravenous, portal, subcutaneous and peritoneal administration.
Fritze K; Fischer U; Freyse EJ; Besch W
Exp Clin Endocrinol; 1988 Mar; 92(3):297-306. PubMed ID: 3075553
[TBL] [Abstract][Full Text] [Related]
3. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
[TBL] [Abstract][Full Text] [Related]
4. Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas.
Matsuo Y; Shimoda S; Sakakida M; Nishida K; Sekigami T; Ichimori S; Ichinose K; Shichiri M; Araki E
J Artif Organs; 2003; 6(1):55-63. PubMed ID: 14598126
[TBL] [Abstract][Full Text] [Related]
5. Current status and future of implantable insulin pumps for the treatment of diabetes.
Catargi B
Expert Rev Med Devices; 2004 Nov; 1(2):181-5. PubMed ID: 16293038
[TBL] [Abstract][Full Text] [Related]
6. Control of glycemia in four routes of insulin administration in diabetic dogs.
Rohde TD; Wigness BD; Rupp WM; Mauer SM; Dorman FD; Chapman RC; Blackshear PJ; Buchwald H
Trans Am Soc Artif Intern Organs; 1983; 29():720-3. PubMed ID: 6369736
[No Abstract] [Full Text] [Related]
7. Control of diabetes through a subcutaneous peritoneal access device (SPAD) in patients with resistance to subcutaneously injected insulin.
Dandona P; Fonseca V; Fernando O; Menon RK; Weerakoon J; Kurtz A; Stephen R
Diabetes Res; 1987 May; 5(1):47-9. PubMed ID: 3304785
[TBL] [Abstract][Full Text] [Related]
8. Continuous intraperitoneal insulin infusion partly restores the glucagon response to hypoglycaemia in type 1 diabetic patients.
Oskarsson PR; Lins PE; Backman L; Adamson UC
Diabetes Metab; 2000 Apr; 26(2):118-24. PubMed ID: 10804326
[TBL] [Abstract][Full Text] [Related]
9. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
10. Chronic intraperitoneal insulin delivery, as compared with subcutaneous delivery, improves hepatic glucose metabolism in streptozotocin diabetic rats.
Mason TM; Gupta N; Goh T; El-Bahrani B; Zannis J; van de Werve G; Giacca A
Metabolism; 2000 Nov; 49(11):1411-6. PubMed ID: 11092503
[TBL] [Abstract][Full Text] [Related]
11. Insulin-mediated glucose disposal in type 1 (insulin-dependent) diabetic subjects treated by continuous subcutaneous or intraperitoneal insulin fusion.
Beylot M; Khalfallah Y; Laville M; Sautot G; Dechaud H; Serusclat P; Berthezene F; Riou JP; Mornex R
Diabete Metab; 1987; 13(4):450-6. PubMed ID: 3315766
[TBL] [Abstract][Full Text] [Related]
12. Tracer kinetic studies of glucose and alanine metabolism in diabetic dogs on the artificial beta cell.
Freyse EJ; Fischer U; Albrecht G
Biomed Biochim Acta; 1984; 43(5):607-14. PubMed ID: 6477544
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous insulin substitution in insulin-dependent diabetes mellitus. Pharmacokinetic and pharmacodynamic studies.
Olsson PO
Acta Med Scand Suppl; 1987; 718():1-78. PubMed ID: 3321929
[TBL] [Abstract][Full Text] [Related]
14. Fasting and postprandial plasma glucose and peripheral insulin levels in insulin-dependent diabetes mellitus and non-insulin-dependent diabetes mellitus subjects during continuous intraperitoneal versus subcutaneous insulin delivery.
Hermans MP; van Ypersele de Strihou M; Ketelslegers JM; Squifflet JP; Buysschaert M
Transplant Proc; 1995 Dec; 27(6):3329-30. PubMed ID: 8539974
[No Abstract] [Full Text] [Related]
15. Metabolic responses to intraduodenal glucose loading in insulin-infused diabetic dogs.
Stevenson RW; Orskov H; Parsons JA; Alberti KG
Am J Physiol; 1983 Aug; 245(2):E200-8. PubMed ID: 6349384
[TBL] [Abstract][Full Text] [Related]
16. Metabolic effects of intensified insulin therapy.
Brunetti P; Bueti A; Antonella MA; Calabrese G; Fabietti PG; Santeusanio F; Massi Benedetti M
Exp Clin Endocrinol; 1984 Apr; 83(2):130-5. PubMed ID: 6373314
[TBL] [Abstract][Full Text] [Related]
17. Near normalization of metabolism of IDDM: comparison of continuous subcutaneous (CSII) versus intraperitoneal (CIPII) insulin delivery.
Gooch BR; Abumrad NN; Robinson RP; Crofford OB
Horm Metab Res; 1984 Dec; 16 Suppl 1():190-4. PubMed ID: 6398261
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous versus intraperitoneal insulin in the management of diabetics on CAPD: a review.
Tzamaloukas AH; Oreopoulos DG
Adv Perit Dial; 1991; 7():81-5. PubMed ID: 1680463
[TBL] [Abstract][Full Text] [Related]
19. Administration of insulin by continuous ambulatory peritoneal dialysis.
Chan E; Montgomery PA
Pharmacotherapy; 1993; 13(5):455-60. PubMed ID: 8247911
[TBL] [Abstract][Full Text] [Related]
20. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
